McKesson OKs $141M Investor Deal Over Generic Price-Fixing

By Bryan Koenig (November 4, 2022, 5:13 PM EDT) -- McKesson will pay shareholders $141 million to resolve class action claims in federal court in California over its allegedly false assertions about generic drug prices that plaintiffs traced to a generic-drug price-fixing conspiracy, according to an investor filing....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!